AZN Stock Summary and Trading Ideas (Astrazeneca PLC - American Depositary Shares | NASDAQ:AZN)

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Astrazeneca PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AZN.

As of January 23, 2026, AZN stock price climbed to $92.95 with 3,842,673 million shares trading.

AZN has a beta of 0.33, meaning it tends to be less sensitive to market movements. AZN has a correlation of 0.05 to the broad based SPY ETF.

AZN has a market cap of $287.98 billion. This is considered a Mega Cap stock.

Last quarter Astrazeneca PLC - American Depositary Shares reported $15 billion in Revenue and $1.19 earnings per share. This beat revenue expectation by $386 million and exceeded earnings estimates by $.05.

In the last 3 years, AZN traded as high as $96.51 and as low as $60.47.

The top ETF exchange traded funds that AZN belongs to (by Net Assets): PVAL, AVDE, DIHP, DFIC, PPH.

AZN has outperformed the market in the last year with a return of +38.6%, while the SPY ETF gained +14.9%. In the last 3 month period, AZN beat the market returning +11.4%, while SPY returned +3.5%. However, in the most recent 2 weeks AZN has underperformed the stock market by returning -1.1%, while SPY returned 0.0%.

AZN support price is $90.32 and resistance is $93.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AZN shares will trade within this expected range on the day.